Skip Nav Destination
1-12 of 12
Keywords: Angiotensin IIClose
Nephron Physiology (2014) 128 (1-2): 8–16.
Published Online: 06 November 2014
... for the manifestation of increased salt intake. Effects of aldosterone on both the brain and kidney synergize with the effects of angiotensin II. Thus, mineralocorticoids appear to induce similar molecular pathways in the kidney, brain, and possibly tongue, which could provide opportunities for more effective...
Nephron Physiology (2010) 115 (1): p1–p7.
Published Online: 10 April 2010
...Marcelo R. Choi; Brenda M. Lee; Cecilia Medici; Alicia H. Correa; Belisario E. Fernández Background/Aims: Dopamine (DA) uptake inhibition in the renal cortex, elicited by angiotensin II (ANG II), is mediated by AT 1 receptors and signals through the phospholipase C pathway and activation of protein...
Nephron Physiology (2009) 111 (4): p55–p60.
Published Online: 17 March 2009
...Marcelo R. Choi; Cecilia Medici; Mariela M. Gironacci; Alicia H. Correa; Belisario E. Fernández Background/Aims: Angiotensin II (ANG II) decreases dopamine (DA) uptake in renal cortex activating AT 1 receptors. We investigated the signaling pathways that mediate this action and the incidence of DA...
Nephron Physiology (2007) 106 (2): p26–p31.
Published Online: 06 June 2007
... with the development and progression of albuminuria. Components of the diabetic milieu (high glucose, accumulation of glycated proteins, high intrarenal angiotensin II (ANG II), and hypertension-induced mechanical stress) result in activation of cytokine systems, the most important of which are transforming growth...
Marcelo R. Choi, Alicia H. Correa, Vanesa del Valle Turco, Fernando Aprile Garcia, Belisario E. Fernández
Nephron Physiology (2006) 104 (4): p136–p143.
Published Online: 01 December 2006
...Marcelo R. Choi; Alicia H. Correa; Vanesa del Valle Turco; Fernando Aprile Garcia; Belisario E. Fernández Background/Aims: Angiotensin II (ANG II) and dopamine (DA) are both important regulators of sodium and water transport across renal proximal tubules. Previous studies demonstrate that atrial...
Nephron Physiology (2006) 103 (3): p149–p156.
Published Online: 22 June 2006
...Christine Maric; Wei Zheng; Thomas Walther Background/Aims: Neutral endopeptidase (NEP) inhibition attenuates renal damage in the diabetic kidney, but little is known about the mechanisms of this renoprotective effect. Methods: We examined the interaction between angiotensin II (Ang II) and atrial...
Nephron Physiology (2005) 101 (4): p77–p81.
Published Online: 14 November 2005
..., instructions or products referred to in the content or advertisements. Ammonia synthesis NH 4 + urinary excretion Acid-base balance regulation Glucocorticoids Angiotensin II Na + -K + (NH 4 + )-2Cl – cotransporter Gene expression mRNA stability Ammonium ion NH 4 + urinary excretion...
Joshua Weissgarten, Sylvia Berman, Shai Efrati, Micha Rapoport, David Modai, Mirel Cohn, Mordechay Aladjem, Elena Galperin, Zhan Averbukh
Nephron Physiology (2005) 101 (1): p14–p20.
Published Online: 19 August 2005
... enzyme inhibitors AT-1 receptor antagonism Angiotensin II Sodium diets © 2005 S. Karger AG, Basel 2005 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...
Nephron Physiology (2005) 99 (3): p90–p100.
Published Online: 24 February 2005
... + -ATPase on microdissected CCD, OMCD and IMCD segments. The effect of angiotensin II AT 1 receptor inhibition and protein recovery (24% protein) on H + -ATPase activity was studied. Methods: Bafilomycin-sensitive H + -ATPase activity on CCD, OMCD and IMCD segments of LP (protein 8%) and control rats CP...
Nephron Physiology (2004) 98 (4): p107–p113.
Published Online: 20 December 2004
...Nobukazu Ishizaka; Kan Saito; Eisei Noiri; Masataka Sata; Ichiro Mori; Minoru Ohno; Ryozo Nagai Background: Angiotensin II infusion into rats causes iron deposition in the kidney, which may augment the pro-proteinuric effects of this octapeptide. We have investigated whether administration of iron...
Junichi Ogata, Kouichiro Minami, Kayoko Segawa, Yasuhito Uezono, Munehiro Shiraishi, Chikako Yamamoto, Takeyoshi Sata, Kim Sung-Teh, Akio Shigematsu
Nephron Physiology (2004) 96 (2): p59–p64.
Published Online: 27 February 2004
... and evaluated the effects of CDH on the noradrenaline (NA) and angiotensin II (AngII) induced increases in blood pressure and reductions in RBF. Continuous intravenous administration of CDH at 0.25 µg/kg/min did not affect the mean arterial pressure (MAP), but increased heart rate and RBF. Continuous...
Steven P. Clavant, Josephine M. Forbes, Vicki Thallas, Tanya M. Osicka, George Jerums, Wayne D. Comper
Nephron Physiology (2003) 93 (2): p51–p60.
Published Online: 20 February 2003
...Steven P. Clavant; Josephine M. Forbes; Vicki Thallas; Tanya M. Osicka; George Jerums; Wayne D. Comper Angiotensin II (ANG II) is intimately involved in normal renal function, and is estimated to exist at a normal physiological range of 6–10 n M within the renal tubules. The potential role...